Summary
The extent of regional atrophy in ten patients, aged 52–74 years, dying with Alzheimer's disease uncomplicated pathologically by the effects of advanced old age or cerebrovascular disease, was quantified by image analysis of fixed coronal brain slices. Atrophy of the cerebral cortex was globally distributed, although the temporal lobe was most severely affected. Grey and white matter was in general affected equally. Atrophy was also present within the basal ganglia, particularly the caudate nucleaus and putamen. Cerebral cortical atrophy is probably due mostly to neurofibrillary degeneration and loss of intrinsic pyramidal cells and their processes (grey matter) and axons (white matter) although loss of ascending subcortical fibres from regions such as nucleus basalis and locus caeruleus will contribute. Atrophy of the basal ganglia may relate to loss of descending cortical projections.
Similar content being viewed by others
References
Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY (1983) The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 40:711–714
Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19:253–262
Cross RB (1982) Demonstration of neurofibrillary tangles in paraffin section: a quick and simple method using Palmgrens technique. Med Lab Sci 39:67–69
De La Monte S (1989) Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25:450–459
Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI (1986) Positron emission tomography in Alzheimer's disease. Neurology 36:879–887
Duyckaerts C, Hauw JJ, Piette F, Rainsard C, Poulin V, Berthaux P, Escourolle R (1985) Cortical atrophy in senile dementia of Alzheimer type is mainly due to a decrease in cortical length. Acta Neuropathol (Berl) 66:72–74
Englund E, Brun A, Alling C (1988) White matter changes in dementia of Alzheimer's type. Brain 111:1425–1439
Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G (1983) Alzheimer's disease: focal changes shown by positron emission tomography. Neurology 33:961–965
Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer type. Positron emission tomography with (18F) fluorodeoxy-glucose. J Comput Assist Tomogr 7:590–598
Haga C, Yamaguchi I, Ikeda K, Kosaka K (1989) PAM modified methenamine silver stain for senile plaques: comparison with β protein immunostaining. Dementia (Japan) 3:417–422
Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI (1986) Neocortical metabolic abnormalities precede non-memory cognitive defects in early Alzheimer's type dementia. Arch Neurol 43:882–885
Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss W-D (1990) Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia (Basel) 1:156–164
Hubbard BM, Anderson JM (1981) A quantitative study of cerebral atrophy in old age and senile dementia. J. Neurol Sci 50:135–145
Mann DMA, Yates PO, Marcyniuk B (1985) Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci 69:139–159
Mann DMA, Brown AMT, Prinja D, Jones D, Davies CA (1990) A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol 16:17–25
Miller AKH, Alston RL, Corsellis JAN (1980) Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser. Neuropathol Appl Neurobiol 6:119–132
Mountjoy CQ, Roth M, Evans NJR, Evans HM (1983) Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol Ageing 4:1–11
Najlerahim A, Bowen DM (1989) Regional weight loss in the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 75:509–512
Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates PO, Davison AN (1986) Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 49:229–237
Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M (1989) β protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 134:243–251
Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS (1985) Anatomical correlates of the distribution of pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 82:4531–4534
Rezek DL, Morris JC, Fulling KH, Gado MH (1987) Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal ageing. Neurology 37:1365–1368
Siegel S (1956) Non-parametric statistics for the behavioural sciences. McGraw-Hill, New York
Skullered K (1985) Variations in the size of the human brain: influence of age, sex, body length, body mass index, alcoholism, Alzheimer changes and cerebral arteriosclerosis. Acta Neurol Scand [Suppl] 102:1–94
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mann, D.M.A. The topographic distribution of brain atrophy in Alzheimer's disease. Acta Neuropathol 83, 81–86 (1991). https://doi.org/10.1007/BF00294434
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00294434